ENLARGE-Lung: A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) in Patients (pts) with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Squamous and Non-Squamous Histology (Stage IIIB/IV) after Prior Chemotherapy

被引：0
|
作者：
Schulz, H.
Sebastian, M. [1 ]
Groeschel, A. [2 ]
Guetz, S. [3 ]
Schuette, W. [4 ]
Mueller-Huesmann, H. [5 ]
von der Heyde, E.
Schumann, C. [6 ]
机构：
[1] Klinikum JW Goethe Univ Frankfurt, Med Klin Hamatol Onkol 2, Frankfurt, Germany
[2] Univ Klinikum Munster, Abt Pneumol, Munster, Germany
[3] Ev Diakonissen Krankenhaus, Leipzig gGmbH, Leipzig, Germany
[4] Stadt Krankenhaus Martha Maria, Innere Med Klin, Klin Innere Med 2, Halle, Saale, Germany
[5] Bruderkrankenhaus St Josef Paderborn, Klin Hamatol & Onkol, Paderborn, Germany
[6] Klinikum Kempten, Klin Immenstadt, Klin Pneumol Thoraxonkol Schlaf & Beatmungsmed, Kempten, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
460
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] ENLARGE-Lung: A national, prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) in patients (Pts) with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) with squamous and non-squamous histology (Stage IIIB/IV) after prior chemotherapy
    Sebastian, M.
    Groeschel, A.
    Guetz, S.
    Schumann, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 295 - 295
  • [2] ENLARGE - Lung: a national, prospective, non-interventional study (NIS) of nivolumab (BMS-936558) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with squamous and non-squamous histology (stage IIIB/IV) after prior chemotherapy
    Sebastian, M.
    Groeschel, A.
    Guetz, S.
    Schumann, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 249 - +
  • [3] ENLARGE-Lung: Two-Year Follow-up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NIS ENLARGE) of Nivolumab after Prior Chemotherapy in Germany
    Guetz, S.
    Schumann, C.
    Groeschel, M.
    Schulte, C.
    Schulz, H.
    Mueller-Huesmann, H.
    Liersch, R.
    von der Heyde, E.
    Wuensch, V
    Sebastian, M.
    [J]. PNEUMOLOGIE, 2020, 74 : S38 - S38
  • [4] Enlarge-Lung: Two-Year Follow-Up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NiS Enlarge) of Nivolumab after Prior Chemotherapy in Germany
    Groeschell, Andreas
    Schumann, Christian
    Guetz, Sylvia
    Schulz, Holger
    Mueller-Huesmann, Harald
    Schulte, Clemens
    Liersch, Ruediger
    von der Heyde, Eyck
    Wuensch, Verena
    Sebastian, Martin
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 117 - 118
  • [5] Real-world evidence: interim analysis of efficacy in 628 patients with stage IIIB/IV non-small cell lung cancer (NSCLC) treated with Nivolumab after prior chemotherapy in a national, prospective, non-Interventional study (ENLARGE-Lung)
    Sebastian, M.
    Groeschel, A.
    Guetz, S.
    Schulz, H.
    Mueller-Huesmann, H.
    Schulte, C.
    Wuensch, V.
    Schumann, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 133 - 133
  • [6] Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)
    Sebastian, Martin
    Groeschel, Andreas
    Guetz, Sylvia
    Schulz, Holger
    Mueller-Huesmann, Harald
    Liersch, Rudiger
    von der Heyde, Eyck
    Wiegand, Joerg
    Ukena, Dieter
    Bargon, Joachim
    Schuette, Wolfgang
    Riera-Knorrenschild, Jorge
    Fischer, Juergen R.
    Griesinger, Frank
    Allan, Victoria
    Waldenberger, Daniela
    Schumann, Christian
    [J]. JOURNAL OF IMMUNOTHERAPY, 2022, 45 (02) : 89 - 99
  • [7] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology
    Sankawa, Yuri
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (03) : 149 - 149
  • [9] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    [J]. LUNG CANCER, 2019, 129 : 35 - 40
  • [10] Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China
    Hu, Shanlian
    Tang, Zhiliu
    Harrison, James P.
    Hertel, Nadine
    Penrod, John R.
    May, Jessica R.
    Juarez-Garcia, Ariadna
    Holdgate, Orban
    [J]. PHARMACOECONOMICS-OPEN, 2023, 7 (02) : 273 - 284
12345